ProShare Advisors’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.9K | Sell |
|
|||||
|
2025
Q1 | $75.5K | Sell |
|
|||||
|
2024
Q4 | $143K | Buy |
|
|||||
|
2024
Q3 | $101K | Buy |
|
|||||
|
2024
Q2 | $71.2K | Sell |
|
|||||
|
2024
Q1 | $96.2K | Buy |
|
|||||
|
2023
Q4 | $99.1K | Buy |
|
|||||
|
2023
Q3 | $56.5K | Buy |
|
|||||
|
2023
Q2 | $82.8K | Buy |
|
|||||
|
2023
Q1 | $86.4K | Sell |
|
|||||
|
2022
Q4 | $107K | Buy |
|
|||||
|
2022
Q3 | $118K | Buy |
|
|||||
|
2022
Q2 | $83K | Sell |
|
|||||
|
2022
Q1 | $204K | Buy |
|